View on Pubmed.gov 25915946 | View on doi.org 10.1371/journal...
Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.
- Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari 'Aldo Moro', Bari, Italy.
- Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari 'Aldo Moro', Bari, Italy; National Cancer Institute, IRCCS Oncologico Giovanni Paolo II, Bari, Italy.
- Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
- Cancer Genetics Laboratory, IRCCS "S. de Bellis", Castellana Grotte, Italy.
- Center for Rare Diseases-Internal Medicine "C. Frugoni", University Hospital of Bari, Bari, Italy.
- US Dermatologia Pediatrica, Ospedale dell'Angelo Ulss 12 Mestre, Venezia, Italy.
- Genetic Counseling Service, Department of Pediatrics, Regional Hospital of Bolzano, Bolzano, Italy.
- Neonatology and NICU Section, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari 'Aldo Moro', Bari, Italy.
- University of Padova, Padova, Italy.
Abstract
BACKGROUND
PIK3CA-related overgrowth spectrum (PROS) include a group of disorders that affect only the terminal portion of a limb, such as type I macrodactyly, and conditions like fibroadipose overgrowth (FAO), megalencephaly-capillary malformation (MCAP) syndrome, congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies (CLOVES) syndrome and Hemihyperplasia Multiple Lipomatosis (HHML). Heterozygous postzygotic PIK3CA mutations are frequently identified in these syndromes, while timing and tissue specificity of the mutational event are likely responsible for the extreme phenotypic variability observed.
METHODS
We carried out a combination of Sanger sequencing and targeted deep sequencing of genes involved in the PI3K/AKT/mTOR pathway in three patients (1 MCAP and 2 FAO) to identify causative mutations, and performed immunoblot analyses to assay the phosphorylation status of AKT and P70S6K in affected dermal fibroblasts. In addition, we evaluated their ability to grow in the absence of serum and their response to the PI3K inhibitors wortmannin and LY294002 in vitro.
RESULTS AND CONCLUSION
Our data indicate that patients' cells showed constitutive activation of the PI3K/Akt pathway. Of note, PI3K pharmacological blockade resulted in a significant reduction of the proliferation rate in culture, suggesting that inhibition of PI3K might prove beneficial in future therapies for PROS patients.
References
Am J Med Genet. 1998 Oct 2;79(4):311-8
Am J Hum Genet. 2012 Jun 8;90(6):1108-15
Hum Mol Genet. 2015 Feb 15;24(4):926-38
Nat Genet. 2014 May;46(5):510-5
Cited by 77 citations (total)
Journal Article Review
Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway.
Electronic publication date April 26, 2017
Neera Nathan [...] Thomas N Darling et al.
Somatic mutations in genes of the PI3K/PTEN/AKT/TSC/mTORC1 signaling pathway cause segmental overgrowth, hamartomas, and malignant tumors. Mosaicism for activating mutations...
Journal Article Review
Neurocutaneous Manifestations of Genetic Mosaicism.
Electronic publication date September 13, 2016
Maurice A M van Steensel
Genetic mosaicism is defined as the presence of two or more genetically distinct cell populations in a single individual. Ever...
Conflict of interest statement
MeSH
- •
Specialties
- •
- •
Substances
- •
- •
- •
- •
- •